Welcome to our dedicated page for SMDCF news (Ticker: SMDCF), a resource for investors and traders seeking the latest updates and insights on SMDCF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SMDCF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SMDCF's position in the market.
SHL Telemedicine Ltd. will present at the Ladenburg Thalmann Virtual Technology Expo on December 7th, 2022, at 9:30 AM ET / 3:30 PM CET. The presentation will feature CEO Erez Nachtomy and CFO Amir Hai. SHL specializes in developing personal telemedicine solutions aimed at cardiovascular health. Interested parties can register for the presentation here. The company is listed on the SIX Swiss Exchange under SHLTN and focuses on telemedicine services utilizing telephonic and Internet technologies.
SHL Telemedicine has appointed Dr. Kimberly J. Henderson and Dr. Joshua H. Atkins to its US Advisory Board as part of its strategic expansion of the SmartHeart® technology in the US. Dr. Henderson brings 17 years of experience, previously serving at CVS Health and currently associated with Mount Sinai. Dr. Atkins, also with 17 years of experience, focuses on respiratory monitoring and patient safety at Penn Medicine. CEO Erez Nachtomy expressed optimism about their contributions toward fast growth in the US market.
On June 30, 2022, SHL Telemedicine announced the appointment of Ehud Barak as Co-Chairman. Barak highlights telemedicine's rising importance, noting SHL's established partnerships with major health organizations like Mayo Clinic and AOK Bayern. His focus will be on enhancing SHL's growth in the US and Germany. The approval of Barak's engagement terms will be presented in a Special General Meeting of Shareholders. SHL specializes in personal telemedicine solutions, primarily targeting cardiovascular care.
FAQ
What is the market cap of SMDCF (SMDCF)?
